Ward et al., 2001 - Google Patents

Exposure to purified lignan from flaxseed (Linum usitatissimum) alters bone development in female rats

Ward et al., 2001

Document ID: 15514640995837877286
Author: Ward W; Yuan Y; Cheung A; Thompson L
Publication year: 2001
Publication venue: British Journal of Nutrition

External Links

Cited by

Snippet

Due to the potential oestrogenic effects of secoisolariciresinol diglycoside (SDG), the mammalian lignan precursor in flaxseed (Linum usitatissimum), we hypothesized that exposure to purified SDG during early life would have a positive effect on developing bone …

Continue reading at www.cambridge.org (PDF) (other versions)

241000700159 Rattus 0 title abstract description 61

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Similar Documents

Publication	Publication Date	Title
Ward et al.	2001	Exposure to purified lignan from flaxseed (Linum usitatissimum) alters bone development in female rats
Collins et al.	2003	Effects of flaxseed and defatted flaxseed meal on reproduction and development in rats
Li et al.	2003	Genistein prevents bone resorption diseases by inhibiting bone resorption and stimulating bone formation
Godfrey	1998	Maternal regulation of fetal development and health in adult life
Setchell et al.	2003	Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies
Turner et al.	1987	Tamoxifen prevents the skeletal effects of ovarian hormone deficiency in rats
Rapuri et al.	2003	Protein intake: effects on bone mineral density and the rate of bone loss in elderly women
Beattie et al.	1992	Trace element nutrition and bone metabolism
De Rensis et al.	2005	Relationships between backfat depth and plasma leptin during lactation and sow reproductive performance after weaning
Rickard et al.	2000	Plasma insulin-like growth factor I levels in rats are reduced by dietary supplementation of flaxseed or its lignan secoisolariciresinol diglycoside
Chen et al.	2009	Flaxseed and pure secoisolariciresinol diglucoside, but not flaxseed hull, reduce human breast tumor growth (MCF-7) in athymic mice
Tojo et al.	1998	Bone structural and metabolic changes at the end of pregnancy and lactation in rats
Kim et al.	2013	The effect of restriction of dietary calcium on trabecular and cortical bone mineral density in the rats
Teng et al.	2020	Effects of low dietary phosphorus on tibia quality and metabolism in caged laying hens
Tomaszewska et al.	2019	Maternal HMB treatment affects bone and hyaline cartilage development in their weaned piglets via the leptin/osteoprotegerin system
Kim et al.	2009	Zinc-deficient diet decreases fetal long bone growth through decreased bone matrix formation in mice
Śliwa et al.	2010	Bone development of suckling piglets after prenatal, neonatal or perinatal treatment with dexamethasone
Donald et al.	1993	Subclinical selenium insufficiency. 4. Effects of selenium, iodine, and thiocyanate supplementation of grazing ewes on their selenium and iodine status, and on the status and growth of their lambs
Fujioka et al.	2007	Differential effects of isoflavones on bone formation in growing male and female mice
Lindsay	1993	Pathogenesis of postmenopausal osteoporosis
Ward et al.	2001	Dietary estrogens of plant and fungal origin: occurrence and exposure
Park et al.	2014	Calcium and vitamin D intake maintained from preovariectomy independently affect calcium metabolism and bone properties in Sprague Dawley rats
Lucia et al.	2003	Dietary arachidonic acid suppresses bone turnover in contrast to low dosage exogenous prostaglandin E2 that elevates bone formation in the piglet
Bajpai et al.	2010	Peripubertal aromatase inhibition in male rats has adverse long-term effects on bone strength and growth and induces prostatic hyperplasia
Wistedt	2013	Shell formation and bone strength in laying hens